Efficacy and safety of Shexiang Baoxin pill in patients with ischemia with non-obstructive coronary arteries (LESS): a phase 4, multicenter, randomized, double-blind, placebo-controlled clinical trial
30 August 2024 (08:00 - 17:30)
Organised by: 

About the speaker

Shanghai Changzheng Hospital, Shanghai (China)
6 More presentations in this session

Doctor K. Vakalis (Harefield, Uxbridge, GB)

Doctor M. Sobral Domingues (Lisbon, PT)
Access the full session
The Event
ESC Congress 2024
30 August - 2 September 2024
You may be interested in
Congress Presentation



